Regulatory Open Forum

 View Only
Expand all | Collapse all

Drug Substance Intermediate- Establishment Registration

  • 1.  Drug Substance Intermediate- Establishment Registration

    Posted 08-Nov-2017 08:49

    ​Good morning everyone,

    Do you know of any requirements/regulations that state that Drug Substance Intermediate Manufacturers need to register their establishment with the FDA? The manufacturer is located outside of the US and we have recently received a question as part of a CRL asking for the manufacturer's FEI number. The establishment registration sections on FDA's website and in the CFR (207) are specific to drug substance/product; not intermediate.

    Thanks,

    Sabrina

    §207.17   Who must register?

    (a) Unless exempt under section 510(g) of the Federal Food, Drug, and Cosmetic Act or this part, all manufacturers, repackers, relabelers, and salvagers must register each domestic establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, and each foreign establishment that manufactures, repacks, relabels, or salvages a drug, or an animal feed bearing or containing a new animal drug, that is imported or offered for import into the United States. When operations are conducted at more than one establishment and common ownership and control among all the establishments exists, the parent, subsidiary, or affiliate company may submit registration information for all establishments.



  • 2.  RE: Drug Substance Intermediate- Establishment Registration

    This message was posted by a user wishing to remain anonymous
    Posted 08-Nov-2017 13:40
    This message was posted by a user wishing to remain anonymous

    ​"​When operations are conducted at more than one establishment and common ownership and control among all the establishments exists, the parent, subsidiary, or affiliate company may submit registration information for all establishments."

    I suppose you are importing this intermediate into the US to complete your API manufacturing? Yes, you will have to register this facility.

    Interesting to see what other say......


  • 3.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 09-Nov-2017 09:23

    The facility should be registered, going back to the "all manufacturers" portion of the quoted regulation.  Over and above the regulation, for FDA to do its job, it is logical to expect that all facilities that perform GMP steps should be registered.

     

    Best regards,

     

    Cathy

     

    Catherine M Anderson, PhD, RAC

    Senior Manager, Regulatory Affairs CMC

     






  • 4.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 09-Nov-2017 09:44

    ​Thank you all! I was recently at the AAM conference and was able to discuss with a few people from industry but also with some people from the FDA; the different FDA representatives I spoke to confirmed that this is a "gray" area for API intermediates manufacturers, they should have an FEI number but don't necessarily need to register.

    I also sent an email to the eDRLS group and they also confirmed that there is no requirement for API intermediate manufacturers to register their establishment under 21 CFR 207.



    ------------------------------
    Sabrina Dessources
    Johnson Matthey
    Devens MA
    United States
    ------------------------------



  • 5.  RE: Drug Substance Intermediate- Establishment Registration

    This message was posted by a user wishing to remain anonymous
    Posted 09-Nov-2017 13:31
    This message was posted by a user wishing to remain anonymous

    ​You may have a problem if the intermediate is being imported from outside US to complete your manufacturing process in the US at the customs/FDA compliance. Just be alert.


  • 6.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 09-Nov-2017 14:17
      |   view attached
    Please see the attachment. 

    The "Intermediate" is highlighted in yellow for your ready reference.


    ------------------------------
    Gaurang Bhavsar, MS, RAC
    Scientist-II, R&D and RA
    Sunrise Pharmaceutical, Inc.
    Rahway, NJ 07065
    USA
    ------------------------------

    Attachment(s)



  • 7.  RE: Drug Substance Intermediate- Establishment Registration

    This message was posted by a user wishing to remain anonymous
    Posted 10-Nov-2017 10:40
    This message was posted by a user wishing to remain anonymous

    "unfinished drugs requiring further processing....." what do you call this? This require drug listing so there seems to be a conflict!!




  • 8.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 10-Nov-2017 11:30
    If this intermediate is part of the API process, where API - Drug substance is not yet completed, then as per yellow highlighted, earlier attached file says it does not require listing.

    If this intermediate is part of the drug product process, where Finished product is not yet formed, but it contains the API, then it needs to be listed.

    It is still unclear that what kind of intermediate you are dealing with. But above is best of my understanding.

    ------------------------------
    Gaurang Bhavsar, MS, RAC
    Scientist-II, R&D and RA
    Sunrise Pharmaceutical, Inc.
    Rahway, NJ 07065
    USA
    ------------------------------



  • 9.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 10-Nov-2017 12:09
    Drug listing and establishment registration are related but separate concepts.  The attachment indicates that API intermediates are not subject to drug listing, meaning that they do not get their own NDC and are not listed as products.  However, establishments that produce API intermediates/regulatory starting materials that are subject to cGMP must be registered, and those establishments and operations must be identified in the listing of the finished product for which they are part of the supply chain.

    If you look under the second paragraph, "Who Should Register?", there is the following:  The term "manufacture" is defined broadly and includes the manufacture, preparation, propagation, compounding, or processing of a drug. These activities include any form of manipulation, sampling, testing or control procedures that are applied to the final product or to any part of the process.

    ------------------------------
    Craig Claussen PhD, RAC

    ------------------------------



  • 10.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 13-Nov-2017 09:53
    ​Thank you all for the additional information. As previously mentioned, the eDRLS office confirmed that there is no requirement for API intermediates manufacturers to register. I personally have a hard time understanding this, especially because of the "broad" definition of manufacture as mentioned by Craig.

    Sabrina


  • 11.  RE: Drug Substance Intermediate- Establishment Registration

    Posted 16-Nov-2017 11:10
    That doesn't make a lot of sense, and they may be taking too narrow a view of the situation.  I am thinking of "API Intermediates" as synonymous with regulatory starting materials or any intermediate material after introduction of RSMs, which would mean anything manufactured under cGMP.  How can we list those sites in S.2.1 and state they are cGMP compliant if they aren't registered and are therefore not subject to FDA inspection?

    ------------------------------
    Craig Claussen PhD, RAC
    ------------------------------